RxDoctor Payments Data

Corinne Griffith, MD

Family Medicine · Raleigh, NCNPI 1285632166

Payments from drug & device makers

$10,751in general payments, 2019–2025

Across 635 payments — averaging $16.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • AbbVie$1K
  • AstraZeneca$830
  • Lilly USA, LLC$803
  • Pfizer$784
  • Amgen$649
  • plus $5K from 39 others

What the payments were for

  • Food & beverage$10,55198%
  • Education$2002%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$10,751 in reported general payments places this provider in the 90th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$59,441
Medicare patients
88
Services billed
626

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide40$63,381
FarxigaDapagliflozin Propanediol31$39,555
TrulicityDulaglutide17$28,281
JardianceEmpagliflozin24$23,621
Repatha SureclickEvolocumab12$11,517
Pitavastatin Calcium30$10,500
JanuviaSitagliptin Phosphate12$6,968
Rosuvastatin Calcium211$2,687
Levothyroxine Sodium214$2,519
Verapamil SrVerapamil Hcl12$2,445
SynthroidLevothyroxine Sodium41$2,319
Valsartan42$1,979
Ibandronate Sodium71$1,900
Potassium Chloride67$1,609
Ezetimibe75$1,607

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,834$63,38140 claims
AstraZenecaFarxiga$830$39,55531 claims
Lilly USA, LLCTrulicity$803$28,28117 claims
Boehringer IngelheimJardiance$490$23,62124 claims
MerckJanuvia$193$6,96812 claims
AbbVieSynthroid, Armour Thyroid$1,070$2,74458 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Raleigh

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →